OwkinBlog

Faced with the rapid spread of COVID-19, research institutions, pharmaceutical, biotech companies, and government institutions across the globe have come together to work in a collective race to understand and discover treatments for this pandemic. Owkin has published a piece in Nature Communications outlining a new AI-based multi-modal COVID-19 risk score, called AI-Severity, which improves …

Continue reading “How to develop a COVID-19 AI-Severity Score in a Race Against a Pandemic”